222 related articles for article (PubMed ID: 27706833)
21. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
22. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
23. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
25. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.
Jinno T; Kawano S; Maruse Y; Matsubara R; Goto Y; Sakamoto T; Hashiguchi Y; Kaneko N; Tanaka H; Kitamura R; Toyoshima T; Jinno A; Moriyama M; Oobu K; Kiyoshima T; Nakamura S
Oncol Rep; 2015 May; 33(5):2161-8. PubMed ID: 25761055
[TBL] [Abstract][Full Text] [Related]
27. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
30. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
[TBL] [Abstract][Full Text] [Related]
31. Tumour budding evaluated in biopsy specimens is a useful predictor of prognosis in patients with cN0 early stage oral squamous cell carcinoma.
Seki M; Sano T; Yokoo S; Oyama T
Histopathology; 2017 May; 70(6):869-879. PubMed ID: 27926795
[TBL] [Abstract][Full Text] [Related]
32. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
34. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
35. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
36. NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma.
Sasahira T; Nishiguchi Y; Kurihara-Shimomura M; Nakashima C; Kuniyasu H; Kirita T
J Cancer Res Clin Oncol; 2018 May; 144(5):875-882. PubMed ID: 29464350
[TBL] [Abstract][Full Text] [Related]
37. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
[TBL] [Abstract][Full Text] [Related]
38. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
39. Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.
Cheng MF; Huang MS; Lin CS; Lin LH; Lee HS; Jiang JC; Hsia KT
Histopathology; 2014 Jul; 65(1):24-34. PubMed ID: 24382204
[TBL] [Abstract][Full Text] [Related]
40. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
